EUVIMEDEUVIMED entdecken
Crossref

Grx attenuates diabetes cataract by activating AMPK/BNIP3/BNIP3L-mediated mitophagy in lens epithelial cells

Jie Zhang, Chenjun Guo, Chao Liang, Xiaona Ning

International Immunopharmacology · 2026-10 · 186 · 117121

DOI: 10.1016/j.intimp.2026.117121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-10. Verfasst von Jie Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710038, China. Electronic address: jessicazhangj…. Hauptthemen laut MEDLINE: Cataract, Epithelial Cells, Lens, Crystalline, AMP-Activated Protein Kinases. Die Arbeit nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glutaredoxin (Grx) plays an important antioxidant role in the pathogenesis of cataracts. Our previous research found that Grx knockout accelerated the occurrence of aging-related cataract (ARC) and was closely related to lens opacity, but the regulatory mechanism of Grx in diabetes cataract (DC) is still unclear. Here, we found that AMPK activity was significantly decreased in the anterior lens capsule of DC patients and high-glucose (HG) treated human lens epithelial cells HLEC-B3, and Grx protein expression and activity were compensatory increased. Moreover, Grx protected HLEC-B3 cells from HG-induced oxidative stress injury and apoptosis, and induced mitophagy. Both AMPK inhibitor (Compound C) and BNIP3 knockdown attenuated these effects. In vivo, Grx alleviated DC by inhibiting oxidative damage, whereas Compound C reversed the protective effect of Grx. In summary, our findings suggest that Grx alleviates DC in rats by activating AMPK to induce BNIP3/BNIP3L-mediated mitophagy. This study provides new experimental evidence and potential targets for the future treatment of DC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CataractEpithelial CellsLens, CrystallineAMP-Activated Protein KinasesMembrane ProteinsGlutaredoxinsProto-Oncogene ProteinsDiabetes ComplicationsAnimalsMitophagyHumansOxidative StressMaleRatsCell LineRats, Sprague-DawleyGlucoseMitochondrial ProteinsSignal TransductionApoptosisTumor Suppressor Proteins

Stichwörter der Autor:innen

AMPK/BNIP3/BNIP3L signaling pathwayDiabetes cataractGrxMitophagyOxidative damage

Substanzen

AMP-Activated Protein KinasesMembrane ProteinsGlutaredoxinsProto-Oncogene ProteinsBNIP3L protein, humanBNIP3L protein, ratGlucoseMitochondrial ProteinsBNIP3 protein, humanTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710038, China. Electronic address: jessicazhangjie114@163.com.
  • Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710038, China.

Zitieren

APA

Zhang, J., Guo, C., Liang, C., & Ning, X. (2026). Grx attenuates diabetes cataract by activating AMPK/BNIP3/BNIP3L-mediated mitophagy in lens epithelial cells. International Immunopharmacology, 186, 117121. https://doi.org/10.1016/j.intimp.2026.117121

Vancouver

Zhang J, Guo C, Liang C, Ning X. Grx attenuates diabetes cataract by activating AMPK/BNIP3/BNIP3L-mediated mitophagy in lens epithelial cells. International Immunopharmacology. 2026;186:117121. doi:10.1016/j.intimp.2026.117121

BibTeX
@article{Zhang2026,
  author = {Zhang, Jie and Guo, Chenjun and Liang, Chao and Ning, Xiaona},
  title = {Grx attenuates diabetes cataract by activating AMPK/BNIP3/BNIP3L-mediated mitophagy in lens epithelial cells},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {186},
  pages = {117121},
  doi = {10.1016/j.intimp.2026.117121}
}
Kostenlos starten →